Acadian Asset Management LLC Vincerx Pharma, Inc. Transaction History

Acadian Asset Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$1.07 - $8.06 $39,130 - $294,762	-36,571 Reduced 87.43%	5,259 $26,000
Q3 2022 Nov 14, 2022	BUY	$0.0 - $1.72 $0 - $29,453	17,124 Added 69.31%	41,830 $56,000
Q3 2022 Nov 14, 2022	BUY	$0.0 - $1.72 $0 - $29,453	17,124 Added 69.31%	41,830 $56,000
Q2 2022 Aug 09, 2022	BUY	$0.0 - $0.0 $0 - $0	24,706 New	24,706 $33,000

11M

Ticker VINC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,189,800
Market Cap $6.57M
Description
Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candid...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.